Compare

AbbVie vs Merck

AbbVie (ABBV) and Merck (MRK) side by side, from official filings: what insiders, members of Congress and funds reported. These are counts of what was filed, not a view on either stock.

AbbVie ABBVNYSE · PharmaceuticalsMerck MRKNYSE · Pharmaceuticals
Insider records, last 12 months88179
Congress trades, last 12 months129
Fund positions reported, last 12 months483451
Federal contract awards, last 12 months811
Open-market purchases by insiders since 20062530
Open-market sales by insiders since 2006537391
Last open-market purchase by an insiderMar 30, 2020Feb 7, 2025
Next resultsOct 30, 2026Oct 29, 2026

Counts of records OQRO holds, by their date. Insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned and automatic sales are included in the sales.

Common questions

Which has had more insider buying, AbbVie or Merck?

Since 2006, Merck insiders reported 30 open-market purchases against 25 for AbbVie, in SEC Forms 4 and 5. Counts depend on the number of insiders and how long each company has been listed.

Do members of Congress trade ABBV or MRK?

In the last 12 months, members of Congress disclosed 12 trades in AbbVie (ABBV) and 9 in Merck (MRK), each reported as a value range on a periodic transaction report.

When did insiders last buy ABBV and MRK?

AbbVie: Mar 30, 2020. Merck: Feb 7, 2025. Dates are those of the SEC filings.

See the record behind any of these

Each company page opens free with one real filing and the counts of the last 12 months. OQRO Pro adds the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.

Get OQRO ProOpen AbbVie free$9.99 a month, cancel anytime

AbbVie pageMerck pageRare insider trades this weekAll comparisons

https://oqro.io/compare/abbv-vs-mrk